Good Manufacturing Practices

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.

Today’s column in the Los Angeles Times is aligned with calls from responsible manufacturers in the dietary supplement industry who agree that regulations need to be modernized and strengthened.

CHPA today applauds the U.S. Food and Drug Administration for enforcing existing provisions in the Federal Food, Drug, and Cosmetic Act by sending warning letters to 15 companies illegally marketing cannabidiol products.

Today CHPA submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol in dietary supplements. 

The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, today released an updated version of the Standardized Information on Dietary Ingredients (SIDI TM) Protocol.

We applaud FDA for focusing their enforcement efforts on homeopathic drug products that do not meet manufacturing standards, contain harmful ingredients, or are OTC products with prescription indications.

CHPA applauds AHPA’s new guidelines on Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material, and acknowledges their importance in helping to ensure the production and supply of high-quality herbal raw materials.